Related Experiment Video
Updated: Nov 27, 2025

A Method of Nodose Ganglia Injection in Sprague-Dawley Rat
Published on: November 25, 2014
An Atypical Presentation of Heroin Inhalation Induced Leukoencephalopathy (Chasing the Dragon)
Muhammad Atif Masood Noori1,2, Sherif Elkattawy2, Islam Younes2
1Internal Medicine, Dow Medical College, Karachi, PAK.
Abstract:
Heroin leukoencephalopathy is associated with 'Chasing the dragon,' which is a heroin vapour inhalation method that is different from smoking or sniffing heroin. The clinical presentation ranges from mild to severe disease. Mild disease is characterized by inattentiveness and ataxia. In moderate diseases, extrapyramidal symptoms predominate, and finally, severe disease is characterized by generalized motor impairment, with death occurring in two-third of cases. We now report a rare presentation of the disease in a 60-year-old female with a past medical history of heroin abuse who presented to ED with signs and symptoms of confusion and restlessness. MRI brain without contrast showed diffuse symmetric increased intensity signals throughout the white matter. Electroencephalogram (EEG) revealed mild diffuse slowing with no lateralization. The patient was started on Vitamin E and was transferred to a rehab facility with following up neurology as an outpatient.
More Related Videos
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Acute Respiratory Failure-IV
Prevention of Further Absorption of Poison
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Dependence
Acute Respiratory Failure-III

